Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Political Opponents in Congress May Find Agreement Over the Benefits of Value-Based Care

Congress may not find a lot of unity to pass legislation. However, there is bipartisan support for value-based care. Melanie Musson, a health insurance expert with USInsuranceAgents.com, reminds providers, “Value-based care improves patient outcome, but it also reduces insurance provider costs.” Following the midterm elections and the split-party control, experts predict that there won’t be…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Congress may not find a lot of unity to pass legislation. However, there is bipartisan support for value-based care. Melanie Musson, a health insurance expert with USInsuranceAgents.com, reminds providers, “Value-based care improves patient outcome, but it also reduces insurance provider costs.”

Following the midterm elections and the split-party control, experts predict that there won’t be many new laws passed. For health insurance providers, the split control could mean that insurance providers won’t have to scramble to keep up with new rules and regulations. Instead, they could spend the next two years focusing on improving procedures and plans.

There is a chance that both political parties could come together for a shared goal of value-based care. The New England Journal of Medicine (NEJM) Catalyst explains that value-based healthcare rewards physicians and hospital systems for patient outcomes rather than for patient treatment.

Value-Based Care Model

This incentive theoretically pushes healthcare providers to identify risks earlier and assist patients in improving their health before it deteriorates. The value-based model seeks not only to improve patient outcomes but also to decrease the average health insurance cost for consumers.

America’s healthcare system costs have far exceeded the rate of inflation, and most of the population wishes something could be done about it. That may give congress the drive to work together to draft legislation that will push insurance providers to shift focus from treatment to prevention.

Rethinking Best Practices

While dealing with the possibility of new rules isn’t fun, it may be in providers’ best interest to shift their focus in that direction before it’s required.

Research backs up the fact that prevention costs less than treatment. The Affordable Care Act pushed healthcare and insurance providers in that direction, but better incentives may help to move that focus forward.

Insurance providers have many rules to adhere to, especially if they offer Medicare Advantage plans. But there is room to incorporate best-value practices even under stringent guidelines.

How Preventative Care Saves Insurers

There are many case studies demonstrating how covering and incentivizing preventative care can save insurance providers. For example, when cancer is caught early, treatment options take less time and require fewer hospitalizations. Cancer that isn’t discovered until later stages may require two times or more treatments and extensive hospitalizations.

Since insurance providers are responsible for paying most of these costs, they can save money by elevating preventative care.

Insurers should always seek to improve their methods, and the bipartisan support of value-based care should prompt them to evaluate how they can incorporate that model into their coverage.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Future of Healthcare Is Already Here: Dr. Geoffrey Rutledge on Virtual Care, AI, and Access

The Future of Healthcare Is Already Here: Dr. Geoffrey Rutledge on Virtual Care, AI, and Access

The article discusses the advancements in healthcare with a focus on virtual care, AI, and access, featuring insights from Dr. Geoffrey Rutledge. It explores how these technologies are shaping the future of healthcare delivery. The conversation touches upon the impact on patient care and the potential for improved healthcare accessibility.

  • 01Virtual care and AI are transforming healthcare.
  • 02These technologies enhance patient accessibility and care.
  • 03Healthcare delivery is continuously evolving with new innovations.

Jul 14, 2026

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512